Transforming growth factor ␤ (TGF-␤) has been shown to participate in the pathophysiology of diabetic complications. As shown most recently, TGF-␤ stimulates the expression of a distinct serine͞threonine kinase (hSGK) which had previously been cloned as an early gene transcriptionally regulated by cell volume alterations. The present study was performed to elucidate transcription and function of hSGK in diabetic nephropathy. As shown by Northern blotting, an increase of extracellular glucose concentration increased hSGK mRNA levels in cultured cells, an effect qualitatively mimicked by osmotic cell shrinkage or treatment with TGF-␤ (2 g͞liter), phorbol 12,13-didecanoate (1 M), or the Ca 2؉ ionophore ionomycin (1 M) and blunted by high concentrations of nifedipine (10 and 100 M). In situ hybridization revealed that hSGK transcription was markedly enhanced in diabetic nephropathy, with particularly high expression in mesangial cells, interstitial cells, and cells in thick ascending limbs of Henle's loop and distal tubules. According to voltage clamp and tracer flux studies in Xenopus oocytes expressing the renal epithelial Na ؉ channel ENaC or the mouse thick ascending limb Na ؉ ,K ؉ ,2Cl ؊ cotransporter BSC-1, coexpression with hSGK stimulated ENaC and BSC-1 11-fold and 6-fold, respectively, effects reversed by kinase inhibitors staurosporine (1 M) and chelerythrine (1 M) and not elicited by inactive hSGK. In conclusion, excessive extracellular glucose concentrations enhance hSGK transcription, which in turn stimulates renal tubular Na ؉ transport. These observations disclose an additional element in the pathophysiology of diabetic nephropathy.
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protein kinase C ͉ endothelial cells ͉ kidney ͉ epithelial Na ϩ channel ͉ Na ϩ ,K ϩ ,2Cl Ϫ cotransporter T ransforming growth factor ␤ (TGF-␤) is considered to be a crucial pathophysiological component in the generation of diabetic nephropathy (1) (2) (3) (4) (5) (6) . A sequence of events has been postulated, which causes the enhanced production of both TGF-␤ and TGF-␤ receptors in hyperglycemia (1, (7) (8) (9) (10) (11) (12) . Excessive extracellular glucose concentrations increase diacylglycerol synthesis (13, 14) and thus lead to activation of protein kinase C (PKC) (12) (13) (14) (15) (16) (17) (18) . Among the PKC isoforms PKC ␣ , PKC ␦ , and PKC are up-regulated, whereas PKC ␤II is down-regulated (19) . Activation of PKC subsequently stimulates the formation of TGF-␤ (20) . The downstream targets of TGF-␤ mediating the pathophysiology of diabetic nephropathy remained largely elusive.
Recently, we identified a downstream target of TGF-␤-i.e., a serine͞threonine kinase (hSGK)-which is transcriptionally up-regulated by TGF-␤ in both U 937 macrophages and HepG2 liver cells (21) . The human SGK has previously been cloned as cell-volume-sensitive gene (22) . The rat SGK was originally identified as a serum-and glucocorticoid-regulated kinase cloned from rat mammary tumor cells (23) but was subsequently shown to be up-regulated by mineralocorticoids (24) . As shown by Northern blot analysis, the human kinase is expressed in all human tissues studied, including pancreas, liver, heart, skeletal muscle, placenta, kidney, and brain (22) . The present study has been performed to search for altered hSGK transcription in diabetic nephropathy and to explore the functional significance of this kinase.
Materials and Methods
Transcriptional Regulation of hSGK in Cultured Cells. 3T3 mouse fibroblasts were maintained in DMEM, supplemented with 10% (vol͞vol) fetal calf serum (FCS) and 1% penicillin͞streptomycin containing 5.5 mM glucose, and human endothelial cells (HMEC-1) were maintained in M199 containing 3.3 M ribose and 5 mM glucose at 37°C and pH 7.4 (5% CO 2 ͞95% air atmosphere), 10% FCS, 10 ng͞ml epidermal growth factor, 1 g͞ml hydrocortisone, and 0.5% gentamycin. Cells were grown to 90% confluency, deprived of FCS for 3 days before stimulation, and, after incubation, homogenized in TRIZOL (Life Technologies͞BRL) (about 0.3 ϫ 10 6 cells per sample). Total RNA was isolated as indicated in the protocol provided by the distributor. Northern blots were prepared with 10, 15, or 20 g of total RNA that had been separated by electrophoresis through 10 g͞liter agarose gels in the presence of 2.2 M formaldehyde. Vacuum blotting (Appligene Oncor Trans DNA Express Vacuum Blotter, Appligene, Heidelberg, Germany) was used for the transfer of the RNA on positively charged nylon membranes (Roche, Mannheim, Germany). The RNA was then cross-linked with the membrane under UV light (UV Stratalinker 2400, Stratagene, Heidelberg, Germany). Hybridization overnight was performed in DIG-Easy-Hyb (Roche, Mannheim) at a probe concentration of 25 g͞liter at 50°C. The digoxigenin (DIG)-labeled probe was generated by PCR as described in detail previously (22) . The quantity of Northern blot signals was measured by scanning densitometry. Where indicated the experiments were performed in the presence of 30 g͞ml neutralizing anti-TGF-␤-1 antibody (R & D Systems, Wiesbaden, Germany).
In Situ Hybridization. Tissue specimens from intact kidneys (n ϭ 7) and from kidneys with diabetic nephropathy (n ϭ 7), taken from patients for diagnostic reasons, were fixed in 4% paraformaldehyde͞0.1 M sodium phosphate buffer (pH 7.2) for 4 h and embedded in paraffin. Normal renal biopsies were obtained from intact parts of kidneys that had been surgically removed because of renal cancer. Diabetic renal biopsies were investigated from patients suffering diabetes type I with a disease duration of 5-12 years. All patients suffered from a persistent proteinuria, Ͼ300 mg͞24 h. Tissue sections (4 m) were deparaffined and hybridized basically as described (25) (26) (27) . The mixture contained either the 35 S-labeled RNA antisense or sense control hSGK probe (21) (500 ng͞ml) in hybridization buffer [10 mM Tris⅐HCl, pH 7.4͞50% (vol͞vol) deionized formamide͞600 mM NaCl͞1 mM EDTA͞0.02% polyvinylpyrrolidone͞0.02% Ficoll͞0.05% BSA͞10% dextran sulfate͞10 mM DTT containing denatured sonicated salmon sperm DNA at 200 g͞ml and rabbit liver tRNA at 100 g͞ml]. Hybridization with RNA probes proceeded at 42°C for 18 h. Slides were then washed as described (25) (26) (27) , followed by 1 h at 55°C in 2ϫ standard saline͞citrate. Nonhybridized single-stranded RNA probes were digested by RNase A (20 g͞ml) in 10 mM Tris⅐HCl, pH 8.0͞0.5 M NaCl for 30 min at 37°C. Tissue slide preparations were autoradiographed (27) and stained with hematoxylin͞eosin.
Coexpression of hSGK with Rat Epithelial Na ؉ Channel (ENaC) or BSC-1.
Xenopus laevis females were purchased from the South African Xenopus facility (Knysna, Republic of South Africa). Oocytes (stages V and VI) were isolated by collagenase treatment as described (28) and allowed to recover overnight. Plasmid DNA of the mouse thick ascending limb Na (22) , and the ␣, ␤, and ␥ subunits of ENaC (29, 30) were linearized with NotI and transcribed in vitro with T7 RNA polymerase in the presence of the cap analog m 7 G(5Ј)ppp(5Ј)G at a concentration of 1 mM. An hSGK K127R mutant was transcribed from a PCR product containing the T7 promoter. cRNA encoding the ␣ and ␤ subunits of ENaC were linearized with BglII and transcribed in vitro with SP6 polymerase. Template cDNA was removed by digestion with RNase-free DNase I. The complementary RNA (cRNA) was purified by extraction with phenol͞chloroform followed by precipitation with 0.5 vol of 7.5 M ammonium acetate and 2.5 vol of ethanol to remove unincorporated nucleotides. The integrity of the transcript was checked by denaturing agarose gel electrophoresis. Na ϩ transport, uptake was determined in oocyte Ringer's solution containing reduced NaCl concentration (rNaOR2: 72.5 mM choline chloride͞10 mM NaCl͞2.5 mM KCl͞1 mM CaCl 2 ͞1 mM MgCl 2 ͞1 mM Na 2 HPO 4 ͞5 mM Hepes, titrated with NaOH to pH 7.8). For each determination, groups of seven cRNA-or noninjected oocytes were washed twice with 4 ml of rNaOR2-buffer. They were then incubated at room temperature in a 5-ml polypropylene tube containing 100 l of the same buffer containing 37 kBq of 22 NaCl. Transport was stopped after 30 min by washing oocytes three times with 4 ml of ice-cold rNAOR2 buffer. Single oocytes were placed in scintillation vials, 3 ml of scintillation fluid was added, and the radioactivity was determined by liquid scintillation counting. Two-Electrode Voltage Clamp and 22 Na ؉ -Flux Measurements. For study of the effect of hSGK on ENaC, oocytes were injected with 5 ng of ␣,␤,␥-ENaC cRNA alone or with 5 ng of ␣,␤,␥-ENaC cRNA ϩ 5 ng of hSGK cRNA per 50 nl of water per oocyte; water-injected oocytes served as controls. All experiments were performed at room temperature 1-2 days after injection. Twoelectrode voltage-clamp recordings were performed at a holding potential of Ϫ80 mV. The data were filtered at 10 Hz and recorded with MacLab digital-to-analog converter and software for data acquisition and analysis (AD Instruments, Castle Hill, Australia) (31) . In all experiments oocytes were superfused with ND96 solution (96 mM NaCl͞2 mM KCl͞1.8 mM CaCl 2 ͞1 mM MgCl 2 ͞5 mM Hepes, pH 7.4). Amiloride-sensitive currents were measured with 30 M amiloride for 2 min. Data are provided as means Ϯ SEM; n represents the number of oocytes investigated. The magnitude of the induced currents varied 2-to 5-fold, depending on the time period after cRNA injection and on the batch of oocytes (from different animals). Therefore, throughout the paper we show experimental data obtained on the same day for each specific set of experiments. All experiments were repeated with at least two or three batches of oocytes; in all repetitions qualitatively similar data were obtained.
Statistical Analysis. Data are expressed as arithmetic means Ϯ SEM and n denotes the number of experiments. Statistical analysis has been made by Student t test or ANOVA, where applicable.
Results
Transcriptional Regulation of SGK in Cultured Cells. SGK transcription in 3T3 fibroblasts increased significantly (P Ͻ 0.05) by 22% Ϯ 7% (n ϭ 4) within 8 h after an increase of extracellular glucose concentration from 5.5 to 30 mM (Fig. 1A) . TGF-␤-1 (2 g͞li- ter) added at 5.5 mM glucose increased significantly (P Ͻ 0.02) SGK transcription in 3T3 fibroblasts within 8 h by 96% Ϯ 20% (n ϭ 4).
To test whether increased extracellular glucose concentrations delay the degradation rather than stimulate the formation of SGK mRNA, actinomycin D (5 g͞ml) was added to inhibit transcription. After a treatment for 6 h with 30 mM glucose to up-regulate SGK mRNA the cells were exposed to actinomycin D in the presence of either 30 mM glucose or in a medium of reduced extracellular osmolarity (190 mOsm) containing 5.5 mM glucose. Osmolarity was reduced because it is known to rapidly decrease hSGK mRNA (22) . As shown in Fig. 1B , the decay of SGK mRNA was similar in the presence of 30 mM glucose and 5.5 mM glucose in hypotonic extracellular fluid. Thus, high extracellular glucose did not appreciably affect mRNA stability.
To test whether an increase of SGK transcription could be similarly elicited in other cells and at shorter exposure times, additional experiments were performed in human endothelial cells. An increase of extracellular glucose concentration from 5.5 mM to 20 mM, 50 mM, or 100 mM increased hSGK mRNA levels of human endothelial cells within 2 h by 35% Ϯ 33% (n ϭ 4), 77% Ϯ 26% (P Ͻ 0.05, n ϭ 4), and 299% Ϯ 129% (P Ͻ 0.05, n ϭ 16), respectively ( Fig. 2A) . After extended exposure to 100 mM glucose, the transcript levels increased further (not shown). Similar to the effect of glucose, osmotic shrinkage of endothelial cells with hypertonic raffinose (100 mM) or NaCl (50 mM) increased hSGK mRNA levels. The respective values approached within 2 h were ϩ389% Ϯ 168% (P Ͻ 0.05, n ϭ 7) for raffinose and ϩ256% Ϯ 42% (P Ͻ 0.01, n ϭ 8) for NaCl.
Because increased cytosolic Ca 2ϩ concentrations have been invoked in the pathophysiology of hyperglycemia (32), we tested for a role of cytosolic Ca 2ϩ in the transcriptional regulation of hSGK. Treatment of the endothelial cells with the Ca 2ϩ ionophore ionomycin (1 M) increased hSGK mRNA levels within 2 h by 536% Ϯ 119% (P Ͻ 0.02, n ϭ 4), indeed pointing to regulation of hSGK transcription by intracellular Ca 2ϩ activity (Fig. 2B) . Conversely, the Ca 2ϩ channel blocker nifedipine decreased within 2 h hSGK transcription by 56% Ϯ 10% (P Ͻ 0.02, n ϭ 4) at 10 M and by 45% Ϯ 24% (n ϭ 4) at 100 M inhibitor (Fig. 2C) . In the presence of nifedipine (10 M or 100 M) 100 mM glucose (2 h) was significantly (P Ͻ 0.05) less stimulatory for hSGK transcription than in the absence of the drug (58% Ϯ 34%, n ϭ 4, and 7% Ϯ 29%, n ϭ 4, respectively).
Phorbol 12,13-didecanoate (PDD) (1 M) increased hSGK transcript levels by 281% Ϯ 94% (P Ͻ 0.05, n ϭ 4), pointing to the regulation of hSGK transcription by PKC (Fig. 2B) . Addition of PDD (1 M) on top of 1 M ionomycin elicited no significant (P Ͻ 0.5) further increase in hSGK mRNA (ϩ670% Ϯ 138%, P Ͻ 0.02, n ϭ 4).
To test whether the effect of high extracellular glucose involves TGF-␤-1, 3T3 fibroblasts were exposed to 30 mM glucose for 8 h in the presence and absence of neutralizing TGF-␤-1 antibody (30 g͞ml), which has been shown to bind endogenously formed TGF-␤. As a result, neutralizing TGF-␤-1 antibody significantly decreased SGK mRNA at 30 mM glucose (Ϫ36% Ϯ 5%, P Ͻ 0.05, n ϭ 3, Fig. 1C) . Moreover, in the presence of the TGF-␤-1 antibody, no significant increase was observed between 5.5 and 30 mM glucose concentration (Ϫ18% Ϯ 10%, n ϭ 3, Fig. 1C ).
In Situ Hybridization. As shown in Fig. 3 A and B , expression of hSGK mRNA in intact kidneys was restricted to some mesangial cells of the glomeruli and a few epithelial cells in distal convoluted tubules and thick ascending limbs of Henle's loop. In contrast, in kidneys with diabetic nephropathy, transcription of hSGK was markedly enhanced in mesangial cells (Fig. 3C ), distal tubules (not shown), and thick ascending limbs of Henle's loop (Fig. 3D ). In addition, high levels of hSGK transcripts were observed in clusters of interstitial cells, most likely representing macrophages and fibroblasts as demonstrated in Fig. 3E . Unspecific labeling of kidney cells was excluded by hybridization of tissue sections with the 35 S-labeled sense control RNA hSGK probe (Fig. 3F) . Fig. 4 , coexpression of ENaC in Xenopus oocytes with hSGK resulted in an 11-fold stimulation of amiloride-sensitive (30 M) currents. At the first day of expression, the measured current was 859 Ϯ 302 nA (n ϭ 5) in ENaC-expressing oocytes and 9,421 Ϯ 2,188 nA (n ϭ 5) in ENaC ϩ hSGK oocytes, the difference being statistically significant (P Ͻ 0.02). The hSGK-induced stimulation of ENaC could be significantly (P Ͻ 0.02) reversed to 93 Ϯ 60 nA and 1,753 Ϯ 614 nA after incubation with the protein kinase inhibitors staurosporine (1 M) or chelerythrine (1 M), respectively for 10 h (n ϭ 5, Fig. 4B ). The consensus sequence for phosphorylation by hSGK has been reported to be RXRXX(S͞T) (33), a sequence found in the ␣ subunit (amino acids 617-622) but not the ␤ and ␥ subunits of ENaC (29) . To test whether hSGK acts through phosphorylation at this hSGK consensus site of the ENaC ␣ subunit, we replaced the serine at position 622 with alanine. As shown in Fig. 4C , the S622A mutant of ENaC ␣ subunit is still rigorously up-regulated by coexpression of hSGK. (Fig. 5) . 
Stimulation of ENaC by hSGK. As shown in
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Discussion
As shown in this study, increased extracellular glucose concentrations increase the mRNA levels of hSGK, a cell-volumeregulated serine͞threonine kinase. Because excessive extracellular glucose concentrations increase expression of both TGF-␤ and TGF-␤ receptor (1, (7) (8) (9) (10) (11) (12) , the enhanced hSGK transcription could have been due to autocrine stimulation by TGF-␤. As a matter of fact, TGF-␤-1 indeed exerts a similarly strong effect on hSGK transcription in fibroblasts (this study) as in U 937 macrophages (21) and HepG2 liver cells (21) . Moreover, the effect of high extracellular glucose concentration is blunted in the presence of neutralizing TGF-␤-1 antibody.
TGF-␤ leads to cell hypertrophy (34) (35) (36) , which has similarly been observed in diabetes mellitus (37) (38) (39) . On the other hand, intriguing evidence has been gathered for cell shrinkage in hyperosmolar diabetes mellitus, resulting in an increased cellular Ca 2ϩ concentration and Ca 2ϩ -dependent cell damage (32, 40, 41) . As the effect of excessive glucose concentrations is mimicked by osmotically equivalent increases of extracellular raffinose and NaCl concentrations, osmotic cell shrinkage could mediate at least part of the early mRNA increase. activates PKC (47, 48) and activation of PKC could increase cytosolic Ca 2ϩ concentration (32, 49) , the two elements of cellular signal transduction are linked. Thus, both cellular mechanisms may converge to a common mechanism up-regulating hSGK transcription.
The present observations not only yield evidence for enhanced expression of hSGK in diabetic nephropathy but shed new light on the physiological function of this kinase-i.e., its ability to stimulate the renal epithelial Na ϩ channel ENaC and the thick ascending limb Na ϩ ,K Ϫ cotransport is a previously undescribed function of hSGK. The effect of ENaC and BSC-1 requires the kinase function, as the inactive mutant does not stimulate the transport proteins. Only the ␣ subunit contains a consensus site for phosphorylation by hSGK (33) . Mutation of this site does, however, not eliminate the stimulatory effect of hSGK on ENaC. Along those lines, aldosterone does not stimulate phosphorylation of the ␣ subunit (53) . Taking these observations together, it is not likely that hSGK activates ENaC by direct phosphorylation. Instead, hSGK apparently stimulates trafficking of ENaC into the cell membrane (54) .
Stimulation of Na ϩ ,K ϩ ,2Cl
Ϫ cotransporter is expected to decrease the delivery of NaCl to the macula densa, to disinhibit tubuloglomerular feedback, and thus to enhance glomerular filtration rate (55) . Hyperfiltration is in turn one of the early and deleterious derangements of renal function in diabetic nephropathy (56) . As a matter of fact, reduced sensitivity of tubuloglomerular feedback has been shown to participate in the hyperfiltration of diabetic nephropathy (57, 58) , and glomerular hyperfiltration could be reversed by inhibition of PKC (59) . Even though other mechanisms may contribute to reduced tubuloglomerular feedback and hyperfiltration in diabetes mellitus (60, 61) , stimulation of Na ϩ ,K ϩ ,2Cl Ϫ cotransporter in thick ascending limbs by hSGK is likely to participate in the generation of 5 . Stimulation of the thick ascending limb Na ϩ ,K ϩ ,2Cl Ϫ cotransporter BSC-1 by hSGK 22 Na ϩ uptake in Xenopus oocytes injected with and without the thick ascending limb Na ϩ ,K ϩ ,2Cl Ϫ cotransporter BSC-1 and͞or the active kinase hSGK or inactive kinase hSGK K127R . In some of the experiments furosemide (100 M) was added to inhibit BSC-1. Arithmetic means Ϯ SEM. diabetic hyperfiltration. Beyond that, stimulation of ENaC and of BSC-1 is expected to induce Na ϩ retention and thus favor the development of hypertensive disease. As stimulation of hSGK transcription by high extracellular glucose concentrations and TGF-␤ is not restricted to renal epithelia, hSGK-mediated stimulation of cellular Na ϩ uptake may occur in a wide variety of cells and may contribute to increased Na ϩ and Ca 2ϩ concentrations seen in diabetic patients (62) . To the extent that altered intracellular electrolyte concentrations are relevant for vascular tone and development of hypertension (62) , enhanced expression of hSGK could further increase blood pressure through an extrarenal mechanism.
In conclusion, we provide evidence that increased extracellular glucose concentrations stimulate the transcription of the cell-volume-regulated kinase hSGK and that hSGK transcription is enhanced in diabetic nephropathy. Because hSGK is a potent stimulator of the renal thick ascending limb Na 
